Meningococcal Vaccine Market size was valued at more than USD 3.57 billion in 2023 and is projected surpass USD 6.33 billion by 2032. The market is predicted to expand at a CAGR of over 5.8% from 2024 to 2032, due to the rising meningococcal vaccine across the globe. The market's growth is being driven by several pivotal factors. Technological advancements play a crucial role, with innovations...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian